Clinical Trial Update: Phase 2B Safety and Efficacy Study of VGT-309 in Subjects With Cancer in the Lung. [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2B safety and efficacy study of VGT-309 in lung cancer and lung metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Lung Metastases

Drugs mentioned

• VGT-309

Snippet

Sponsor: Vergent Bioscience, Inc. | Conditions: Lung Cancer, Lung Metastases | Phase 2 | Status: COMPLETED